YS-5

N/A

Report date: 2023/01/07 18:44:49

Base Information

Drug NameYS-5
Drug Alias NameYS-5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-MCP
TargetsMembrane cofactor protein
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUnited States Department Of DefenseFortis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUnited States Department Of DefenseFortis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A